Stereotactic Planning Software Market
By Solution Type;
Stand-Alone Stereotactic Planning Solution, Integrated Stereotactic Planning Solution, Services, Consulting & Implementation, Training Services and On-Demand Support ServicesBy Imaging Modality;
CT Images, MR Images and Angiographic ImagesBy End User;
Hospitals, Ambulatory Surgical Centers and Cancer Research InstitutesBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Stereotactic Planning Software Market Overview
Stereotactic Planning Software Market (USD Million)
Stereotactic Planning Software Market was valued at USD 318.00 million in the year 2024. The size of this market is expected to increase to USD 435.66 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.6%.
Stereotactic Planning Software Market
*Market size in USD million
CAGR 4.6 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 4.6 % |
| Market Size (2024) | USD 318.00 Million |
| Market Size (2031) | USD 435.66 Million |
| Market Concentration | High |
| Report Pages | 354 |
Major Players
- Inomed Medizintechnik GmbH
- Renishaw plc
- Brainlab AG
- Micromar Ind. Com. Ltda.
- Elekta AB
- Neurostar
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Stereotactic Planning Software Market
Fragmented - Highly competitive market without dominant players
Stereotactic Planning Software Market is gaining momentum as neurosurgeons and radiation oncologists increasingly adopt precision-targeted planning tools for procedures like deep brain stimulation, lesion ablation, and radiosurgery. Nearly 65% of surgical centers now utilize planning software to enhance target accuracy and patient safety, driving heightened innovation and market expansion, supported by clinical–technology integration.
Technological Advancements Elevating Planning Accuracy
About 62% of software developers are enhancing platforms with features such as multimodal imaging fusion, AI‑driven trajectory optimization, real-time deformation modeling, and surgical navigation interface integration. These are transformative technological advancements that elevate procedural precision. Collaboration between neurosurgical teams and software engineers accelerates effective planning tool development.
Collaborative Adoption Ensuring Clinical Efficacy
Cross-disciplinary adoption initiatives among surgeons, radiologists, and academic institutions have led to a 59% increase in software use for stereotactic treatments. These cross-functional collaborations support training programs, standardized planning protocols, and system validation contributing to growth through integrated clinical implementation.
Strategic Partnerships Unifying Technology and Care Networks
Approximately 63% of recent market progress is driven by strategic partnerships and joint ventures between software firms, surgical device makers, and hospital systems. These collaborations improve interoperability, streamline workflow integration, and enhance training support fostering sustained market expansion and platform adoption.
Stereotactic Planning Software Market Key Takeaways
-
The market for stereotactic planning software is experiencing growth due to rising prevalence of neurological disorders and brain cancers, which increases demand for precise and minimally invasive surgical procedures.
-
Advances in imaging and AI‑driven planning tools including multimodal image fusion, machine‑learning trajectory optimization, and real‑time navigation integration are enhancing surgical accuracy and expanding adoption.
-
Hospitals and ambulatory surgical centers remain primary end‑users, as they have required infrastructure, imaging modalities and skilled personnel to leverage these planning systems effectively.
-
Applications such as biopsy planning and deep brain stimulation (DBS) account for a large share of usage, given the need for high‑precision targeting in lesion sampling and treatment of movement disorders.
-
Growing demand for personalized and minimally invasive procedures is driving adoption, as stereotactic planning enables tailored treatment plans that minimize damage to healthy tissue and improve patient outcomes.
-
Despite advantages, high implementation cost and requirement for specialized training limit adoption in smaller clinics or regions with constrained healthcare budgets.
-
Markets in North America and Europe currently hold majority share due to advanced healthcare infrastructure, while Asia‑Pacific and emerging regions present strong growth potential driven by rising healthcare investments and expanding neurosurgical capabilities.
Stereotactic Planning Software Market Recent Developments
-
In July 2020, RaySearch Laboratories AB established a wholly-owned subsidiary in Australia to enhance its service and support across the Australian and New Zealand markets. This strategic move aims to strengthen the company’s regional presence and improve accessibility to its advanced oncology software solutions.
-
In October 2020, Brainlab formed a partnership with Accuray Incorporated to enhance the CyberKnife therapy platform, with a focus on advancing neuro-radiosurgery applications. This collaboration aims to integrate precision technologies that improve accuracy and treatment outcomes in radiosurgical procedures.
Stereotactic Planning Software Market Segment Analysis
In this report, the Stereotactic Planning Software Market has been segmented by Solution Type, Imaging Modality, End User and Geography.
Stereotactic Planning Software Market, Segmentation by Solution Type
The Solution Type segmentation divides offerings into stand‑alone planning software, integrated platforms, and a suite of supporting services — reflecting varied institutional readiness, technical capability, and investment tolerance. This segmentation helps vendors and purchasers align their software procurement with clinical volume, infrastructure, and staff expertise requirements. It captures fundamental choices between cost‑efficient flexibility and full‑workflow integration, and delineates service components critical for deployment, compliance, and long‑term sustainability.
-
Stand‑Alone Stereotactic Planning Solution
Stand‑alone planning solutions offer core functionality for target delineation, imaging import/export, and trajectory planning without requiring integration with imaging or navigation hardware. They are well suited for centers with limited infrastructure or those seeking modular capability expansion. Their flexibility, lower initial cost, and minimal dependencies make them attractive to smaller hospitals, outpatient centers, or research institutes beginning stereotactic workflows.
-
Integrated Stereotactic Planning Solution
Integrated solutions embed planning software directly within imaging, navigation or surgical/radiosurgical platforms — enabling seamless workflow, real‑time data exchange, and higher procedural accuracy. This approach reduces manual transfer errors, supports multimodal imaging registration, and enhances procedural efficiency. Institutions with higher case volumes and stringent quality demands often prefer integrated solutions for their robustness, interoperability, and capacity to support complex stereotactic procedures.
-
Services – Consulting & Implementation
Consulting and implementation services assist institutions in system setup, workflow integration, software configuration, compliance setup, and initial deployment — crucial for facilities with limited in‑house technical expertise. These services help ensure proper calibration, staff training, regulatory readiness, and smooth transition from legacy systems. They lower adoption barriers and support safe, standardized implementation of stereotactic planning solutions.
-
Services – Training Services
Training services provide clinicians, radiologists, and technical staff with required competencies for effective software use — including imaging registration, target delineation, trajectory simulation, and safety protocol adherence. Given the complexity of stereotactic planning, comprehensive training ensures procedural accuracy, reduces operator error, and fosters confidence among end users. This sub‑segment supports wider adoption across centers of varying size and technical capacity.
-
Services – On‑Demand Support Services
On‑demand support services offer ongoing maintenance, troubleshooting, version upgrades, and technical assistance — essential for continuity, compliance, and reliability in critical clinical environments. This service segment ensures system stability, timely updates, and rapid support in emergent or high‑throughput scenarios. For many end users, robust support and service availability are key factors influencing long‑term adoption and operational success.
Stereotactic Planning Software Market, Segmentation by Imaging Modality
The market segmentation by Imaging Modality distinguishes planning workflows based on input data type: CT, MR, or angiographic imaging. This axis reflects how modality choice influences planning accuracy, suitability for particular procedures, and compatibility with software features. Differentiating by modality enables providers and vendors to match software capabilities to clinical needs — whether bone‑focused interventions, soft‑tissue targeting, or vascular lesion planning — optimizing outcomes and resource utilization.
-
CT Images
CT‑based planning is widely used for procedures requiring high spatial resolution, bone landmark referencing, or when speed and image availability are priorities. Its relative ubiquity in diagnostic imaging makes CT‑compatible planning software accessible to many hospitals and centers. This modality supports efficient imaging‑to‑plan workflows, especially where bone structure or calcified lesions are involved, facilitating broad adoption across resource settings.
-
MR Images
MR‑based planning offers superior soft‑tissue contrast, enhancing delineation of tumors, lesions and neural structures — critical for neurosurgical and radiosurgical procedures. This modality is essential for high‑precision, soft‑tissue targeted interventions where accuracy in anatomical definition matters significantly. MR‑compatible software supports advanced planning demands and is often preferred in tertiary care centers and specialty neuro‑oncology institutions.
-
Angiographic Images
Planning based on angiographic imaging facilitates interventions involving vascular anomalies, arteriovenous malformations, aneurysms, and vascular‑rich tumors by allowing detailed vascular mapping and trajectory planning. Software supporting angiographic data enables surgeons to avoid critical vessels, minimize procedural risks, and tailor surgical or minimally invasive approaches. This modality is key for centers specializing in vascular neurosurgery, interventional neuroradiology, or hybrid procedures requiring vascular navigation precision.
Stereotactic Planning Software Market, Segmentation by End User
The End User segmentation categorizes organizations that deploy stereotactic planning software — including hospitals, ambulatory surgical centers (ASCs), and cancer research institutes — reflecting differences in procedural volume, infrastructure, resource allocation, and clinical scope. This segmentation helps vendors and stakeholders tailor solutions to distinct institutional needs and capacity, guiding sales, support, and deployment strategies accordingly.
-
Hospitals
Hospitals — particularly tertiary, neurology, oncology, and comprehensive care centers — represent a primary end‑user group due to high patient throughput, diverse case mix, and need for high‑precision surgical or radiosurgical planning. Their infrastructure, imaging capacity, and multidisciplinary teams support adoption of integrated planning solutions with full functionality. Hospitals typically demand robust support, compliance, training, and long‑term maintenance along with software procurement.
-
Ambulatory Surgical Centers
Ambulatory Surgical Centers (ASCs) offering outpatient neurosurgical, neuro‑oncology, or minimally invasive procedures increasingly adopt planning software to enable efficient, safe, and cost‑effective care outside traditional hospital settings. These centers may favor stand‑alone or lightweight integrated solutions depending on imaging capacity and procedural volume. Adoption by ASCs signals decentralization of stereotactic procedures and growing market penetration beyond large hospitals.
-
Cancer Research Institutes
Cancer research institutes, academic centers, and specialized neuro‑oncology labs use stereotactic planning software for research, clinical trials, treatment protocol development, and experimental interventions. Their needs often include flexibility, multi‑modality support, imaging registration, and advanced planning capabilities such as 3D modelling or simulation. This segment drives demand for customizable software packages, service support, and training tailored to research workflows and investigational use‑cases.
Stereotactic Planning Software Market, Segmentation by Geography
The geographic segmentation divides the global market into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Regional variation in clinical infrastructure, imaging modality penetration, neurosurgical capacity, healthcare investment, and regulatory environment drives differences in market adoption, software preferences, and growth potential. Geography segmentation helps vendors and investors prioritize markets, plan distribution and support strategies, and align product offerings with regional needs and capacities.
Regions and Countries Analyzed in this Report
North America
North America leads the global stereotactic planning software market, supported by advanced neurosurgical infrastructure, high penetration of MR and CT imaging systems, strong oncology and neurology care capacity, and robust demand for minimally invasive procedures. Early adoption of integrated software solutions, combined with emphasis on technological innovation, regulatory compliance, and quality‑driven workflows, underpins market dominance in this region. The presence of major academic centers, high healthcare expenditure, and supportive reimbursement frameworks further drive consistent growth.
Europe
Europe represents a mature and stable market with widespread adoption of stereotactic planning software across hospitals, cancer centers, and research institutes. Strong emphasis on clinical standards, patient safety, and regulatory oversight encourages uptake of both stand‑alone and integrated planning solutions. Investment in imaging infrastructure, neurosurgical services, and oncological care — along with well‑established public health systems — sustains demand for advanced planning tools throughout the region.
Asia Pacific
Asia Pacific shows high growth potential for stereotactic planning software as healthcare infrastructure expands, imaging modality penetration increases, and demand for neurosurgical and oncology procedures rises. Emerging economies in this region are expanding hospital networks, investing in diagnostic and surgical facilities, and raising access to advanced care — creating significant opportunity for both stand‑alone and integrated software adoption. Rapid population growth, rising disease burden, and increasing medical tourism further amplify market prospects.
Middle East & Africa
Middle East & Africa region is gradually advancing in adoption of stereotactic planning software as imaging capability, neurosurgical infrastructure, and oncology care evolve. While penetration remains lower compared to developed regions, growing healthcare investment, rising demand for advanced diagnostics, and increasing partnerships with global vendors create opportunities for market growth. Vendors offering scalable, cost‑effective solutions with strong service & support models may find early traction in this region.
Latin America
Latin America represents a developing but promising market for stereotactic planning software, driven by increasing healthcare investment, expanding hospital and diagnostic center capacity, and growing demand for minimally invasive surgical and oncologic care. Given cost sensitivity and variable infrastructure, many centers may initially adopt stand‑alone solutions or service‑based deployment models, with potential to upgrade to integrated systems over time. As neurosurgery and oncology care expand, demand for planning software is likely to accelerate.
Stereotactic Planning Software Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Stereotactic Planning Software Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Machine Learning Algorithms
- Cloud-Based Platforms
- Interoperable Systems
-
Improved Patient Outcomes -The stereotactic planning software market is not only driving technological advancements but also significantly impacting patient outcomes across various medical specialties. One of the key areas where stereotactic planning software has led to improved patient outcomes is in neurosurgery. By providing precise localization and targeting of treatment areas, this software enables neurosurgeons to perform complex procedures with greater accuracy and efficiency, ultimately leading to better outcomes for patients undergoing brain surgeries or treatments for neurological conditions such as Parkinson's disease and epilepsy.
Stereotactic planning software plays a crucial role in enhancing treatment precision while minimizing damage to surrounding healthy tissues. This precision leads to improved tumor control rates and reduced side effects for cancer patients undergoing radiation treatment. With advancements such as image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT), clinicians can tailor treatments more precisely to individual patients, thereby optimizing outcomes and improving quality of life.
The use of stereotactic planning software is expanding into other medical specialties, such as otolaryngology, orthopedics, and cardiology, where it is contributing to improved patient outcomes through enhanced surgical precision and reduced complications. For example, in otolaryngology, the software aids in the precise navigation of complex sinus surgeries and skull base procedures, leading to better outcomes for patients with sinus disorders or tumors. In orthopedic surgery, it facilitates the accurate placement of implants during spinal surgeries and joint replacements, resulting in improved post-operative function and reduced risk of complications. Similarly, in cardiology, stereotactic planning software is utilized for minimally invasive cardiac procedures, such as catheter ablation for arrhythmias, leading to improved outcomes and shorter recovery times for patients with heart rhythm disorders.
Overall, the widespread adoption of stereotactic planning software across various medical specialties is revolutionizing patient care by enabling clinicians to deliver more precise and personalized treatments. As technology continues to advance and healthcare providers gain more experience with these systems, the potential for further improvements in patient outcomes is substantial, paving the way for a brighter future in healthcare delivery.
Restraints:
- High cost of implementation
- Concerns regarding data security and privacy
- Complex regulatory landscape
-
Limited accessibility in certain regions -While the stereotactic planning software market is experiencing robust growth, there are challenges related to limited accessibility in certain regions. Despite the widespread adoption of advanced medical technologies in many parts of the world, disparities in healthcare infrastructure and resources can hinder the availability of stereotactic planning software in some regions.
One of the primary factors contributing to limited accessibility is the uneven distribution of healthcare facilities and resources. In underserved regions with limited access to specialized medical equipment and expertise, the adoption of stereotactic planning software may be delayed or restricted. This disparity can result in unequal access to advanced treatment options for patients in these areas.
Economic factors play a significant role in accessibility. The high cost associated with acquiring, implementing, and maintaining stereotactic planning software can pose barriers, particularly for healthcare institutions in low-income regions. Budget constraints may limit investment in advanced medical technologies, further exacerbating disparities in access to stereotactic planning software.
Regulatory challenges and infrastructure limitations can impede the adoption of stereotactic planning software in certain regions. Lack of standardized regulations, inadequate training programs for healthcare professionals, and insufficient IT infrastructure may hinder the integration and utilization of this technology in healthcare systems.
The issue of limited accessibility requires collaborative efforts from stakeholders across the healthcare ecosystem. This includes government bodies, healthcare providers, technology vendors, and non-profit organizations working together to improve infrastructure, expand training programs, and facilitate technology transfer to underserved regions.
Initiatives aimed at reducing the cost of stereotactic planning software, such as subsidies, grants, and technology-sharing agreements, can help make these solutions more accessible to healthcare institutions in resource-constrained settings. Additionally, capacity-building efforts, including training programs and knowledge transfer initiatives, can empower local healthcare professionals to effectively utilize stereotactic planning software, thereby improving patient outcomes and narrowing the accessibility gap.
Opportunities:
- Remote Collaboration
- Patient-Centric Care
- Regulatory Harmonization
-
Personalized Healthcare -The stereotactic planning software market is witnessing significant growth, driven by increasing demand for precise and efficient treatment planning in healthcare. Stereotactic planning software plays a crucial role in guiding surgeons during minimally invasive procedures, allowing for precise targeting of tissues while minimizing damage to surrounding healthy tissue. This technology is particularly important in the field of personalized healthcare, where treatment approaches are tailored to individual patients based on their unique characteristics and medical histories.
Personalized healthcare emphasizes the importance of considering each patient's specific needs and circumstances when making treatment decisions. Stereotactic planning software enables healthcare providers to create highly customized treatment plans that take into account factors such as the size, location, and characteristics of a patient's tumor or lesion. By optimizing treatment delivery and minimizing collateral damage, these advanced planning tools help improve patient outcomes and reduce the risk of complications.
The increasing prevalence of conditions such as cancer and neurological disorders is driving the adoption of stereotactic planning software in healthcare facilities worldwide. As healthcare providers strive to deliver more effective and personalized treatments, the demand for innovative planning solutions is expected to continue growing. Additionally, ongoing advancements in technology, such as the integration of artificial intelligence and machine learning algorithms, are further enhancing the capabilities of stereotactic planning software, enabling even greater precision and efficiency in treatment planning.
In conclusion, the stereotactic planning software market is poised for continued growth, fueled by the rising demand for personalized healthcare and the increasing prevalence of complex medical conditions. As technology continues to evolve, stereotactic planning software will play an increasingly important role in enabling healthcare providers to deliver targeted, effective treatments that are tailored to the unique needs of each patient.
Stereotactic Planning Software Market Competitive Landscape Analysis
Stereotactic Planning Software Market is shaped by strong competition where companies emphasize precision, integration, and advanced features to maintain relevance. The market is driven by consistent demand for treatment accuracy, with nearly 65% of leading firms enhancing solutions through innovation, collaboration, and partnerships. Strategic mergers further boost their positions, creating sustained growth in this specialized software landscape.
Market Structure and Concentration
The market shows a moderately consolidated structure, with the top 40% of vendors controlling significant influence. Larger firms rely on strategies like mergers and partnerships to expand portfolios, while niche developers leverage innovation to remain competitive. Concentration levels highlight ongoing expansion as new entrants introduce targeted functionalities to gain clinical adoption.
Brand and Channel Strategies
Vendors deploy multi-channel strategies that include direct sales, distributor networks, and digital platforms to secure a broader customer base. Over 55% focus on strengthening brand positioning by aligning with research centers through collaboration and partnerships. These approaches reinforce credibility and enable sustainable growth across diversified healthcare ecosystems.
Innovation Drivers and Technological Advancements
Continuous technological advancements are central, with more than 70% of leading providers integrating AI and cloud-based systems into planning workflows. This wave of innovation enhances imaging precision and interoperability. Companies also pursue collaboration with hospitals and research institutions, fostering growth through joint development of customized stereotactic planning platforms.
Regional Momentum and Expansion
Regional adoption trends indicate over 60% market concentration in advanced healthcare economies, driven by expansion of digital infrastructures. Vendors adopt regional strategies such as partnerships with local distributors to strengthen access. Cross-border collaboration supports knowledge exchange and accelerates growth, creating balanced participation across both developed and emerging clinical environments.
Future Outlook
The future of this market reflects promising growth, with nearly 68% of stakeholders prioritizing strategies that focus on interoperability and workflow efficiency. Increased collaboration, alongside strategic mergers and partnerships, will continue to redefine product capabilities. The emphasis on technological advancements positions stereotactic planning software for sustainable expansion across healthcare frameworks.
Key players in Stereotactic Planning Software Market include.
- Brainlab
- Elekta
- Renishaw
- RaySearch Laboratories
- inomed Medizintechnik
- Varian Medical Systems
- GE Healthcare
- Philips
- MIM Software
- Neurostar
- Micromar
- IBA Worldwide
- Accuray
- Medizintechnik GmbH
- FHC
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Solution Type
- Market Snapshot, By Imaging Modality
- Market Snapshot, By End User
- Market Snapshot, By Region
- Stereotactic Planning Software Market Forces
- Drivers, Restraints and Opportunities
- Drivers
-
Machine Learning Algorithms
-
Cloud-Based Platforms
-
Interoperable Systems
-
Improved Patient Outcomes
-
- Restraints
-
High cost of implementation
-
Concerns regarding data security and privacy
-
Complex regulatory landscape
-
Limited accessibility in certain regions
-
- Opportunities
-
Remote Collaboration
-
Patient-Centric Care
-
Regulatory Harmonization
-
Personalized Healthcare
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Stereotactic Planning Software Market, By Solution Type, 2021 - 2031 (USD Million)
- Stand-Alone Stereotactic Planning Solution
- Integrated Stereotactic Planning Solution
- Services
- Consulting & Implementation
- Training Services
- On-Demand Support Services
- Stereotactic Planning Software Market, By Imaging Modality, 2021 - 2031 (USD Million)
- CT Images
- MR Images
- Angiographic Images
- Stereotactic Planning Software Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Stereotactic Planning Software Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Stereotactic Planning Software Market, By Solution Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Brainlab
- Elekta
- Renishaw
- RaySearch Laboratories
- inomed Medizintechnik
- Varian Medical Systems
- GE Healthcare
- Philips
- MIM Software
- Neurostar
- Micromar
- IBA Worldwide
- Accuray
- Medizintechnik GmbH
- FHC
- Company Profiles
- Analyst Views
- Future Outlook of the Market

